Authors:
Wang, XY
Shimizu-Sasamata, M
Moskowitz, MA
Newcomb, R
Lo, EH
Citation: Xy. Wang et al., Profiles of glutamate and GABA efflux in core versus peripheral zones of focal cerebral ischemia in mice, NEUROSCI L, 313(3), 2001, pp. 121-124
Authors:
Ayata, C
Shimizu-Sasamata, M
Lo, EH
Noebels, JL
Moskowitz, MA
Citation: C. Ayata et al., Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha 1A subunit of P/Q typecalcium channels, NEUROSCIENC, 95(3), 2000, pp. 639-645
Authors:
Kawasaki-Yatsugi, S
Ichiki, C
Yatsugi, S
Takahashi, M
Shimizu-Sasamata, M
Yamaguchi, T
Minematsu, K
Citation: S. Kawasaki-yatsugi et al., Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model, NEUROPHARM, 39(2), 2000, pp. 211-217
Authors:
Ni, JW
Takahashi, M
Yatsugi, S
Shimizu-Sasamata, M
Yamaguchi, T
Citation: Jw. Ni et al., Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats, NEUROREPORT, 9(16), 1998, pp. 3719-3724
Authors:
Kawasaki-Yatsugi, S
Shimizu-Sasamata, M
Yatsugi, SI
Yamaguchi, T
Citation: S. Kawasaki-yatsugi et al., Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats, J PHARM PHA, 50(8), 1998, pp. 891-898
Authors:
Kohara, A
Okada, M
Tsutsumi, R
Ohno, K
Takahashi, M
Shimizu-Sasamata, M
Shishikura, J
Inami, H
Sakamoto, S
Yamaguchi, T
Citation: A. Kohara et al., In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, J PHARM PHA, 50(7), 1998, pp. 795-801